Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity is a research paper published in Journal of Lipid Research (2020). On theSindex it has a DataRank of 2.2. It has been cited 50 times, with 50 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.590
From this paper's citation signal
Citation Network Contribution
1.6
From 45 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 50 citers.
National Institutes of Health
Grant: DK54320
National Institutes of Health
Grant: GM1129465
National Institutes of Health
Grant: T32 HL07343
National Institutes of Health
Grant: 5T32HL007343-48
Postdoctoral Training in Arteriosclerosis Research
National Institutes of Health
Grant: 5R01DK054320-07
Sterol Sensing and Transport in Model Eukaryote
NIDDK NIH HHS
Grant: R01 DK054320
NHLBI NIH HHS
Grant: T32 HL007343
NIGMS NIH HHS
Grant: R01 GM129465
FWCI
7.46
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals